scholarly article | Q13442814 |
P356 | DOI | 10.1148/RADIOLOGY.183.3.1316622 |
P953 | full work available at URL | http://pubs.rsna.org/doi/pdf/10.1148/radiology.183.3.1316622 |
P698 | PubMed publication ID | 1316622 |
P2093 | author name string | Takashima T | |
Nonomura A | |||
Matsui O | |||
Kadoya M | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 819-825 | |
P577 | publication date | 1992-06-01 | |
P1433 | published in | Radiology | Q3285690 |
P1476 | title | Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings | |
P478 | volume | 183 |
Q90477729 | A case of pseudoglandular hepatocellular carcinoma: The usefulness of a multimodal approach |
Q73305770 | Ablation of hepatocellular carcinoma by percutaneous ethanol injection: imaging findings |
Q47730953 | Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. |
Q38058687 | Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma. |
Q33830807 | Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor |
Q41962614 | Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
Q52412386 | Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. |
Q34959633 | Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis |
Q34681076 | CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects |
Q34682228 | CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features |
Q55296234 | CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners. |
Q38684422 | Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI. |
Q71311709 | Ciliated foregut cyst in cirrhotic liver |
Q37136402 | Correlation of magnetic resonance signal characteristics and perfusion parameters assessed by volume perfusion computed tomography in hepatocellular carcinoma: Impact on lesion characterization |
Q33561375 | Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology |
Q97543784 | Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infecte |
Q36873459 | Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges |
Q71102120 | Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments |
Q37488855 | Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease |
Q41074605 | Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis |
Q34922580 | Imaging evaluation of hepatocellular carcinoma |
Q53065079 | Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases. |
Q72328809 | Intrahepatic bile duct dilatation secondary to hepatocellular carcinoma: CT features in 10 patients |
Q61799346 | LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance |
Q42320233 | Liver Imaging Reporting and Data System: an expert consensus statement |
Q73496943 | Liver Metastases from Colon Cancer with Intra-Bile Duct Tumor Growth: Radiologic Features |
Q78073632 | MR imaging of hepatocellular carcinoma |
Q33783910 | MR imaging of the liver: techniques and clinical applications |
Q35619951 | MRI features of hepatocellular carcinoma related to biologic behavior |
Q39975299 | MRI in detection of hepatocellular carcinoma (HCC). |
Q36291622 | MRI of Focal Liver Lesions |
Q41721368 | Magnetic resonance imaging of focal and diffuse hepatic disease |
Q34544251 | Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis |
Q26770020 | Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues |
Q41729093 | Pediatric hepatic imaging |
Q53241493 | Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology. |
Q70851601 | Pictorial essay: imaging of liver tumors in the infant and child |
Q48358723 | Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study. |
Q41729061 | Primary hepatic malignant neoplasms |
Q51887478 | Prospective comparison of high- and low-spatial-resolution dynamic MR imaging with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinoma. |
Q71314723 | Radiologic diagnosis of hepatocellular carcinoma |
Q53128896 | Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy. |
Q34663392 | Rational imaging of hepatocellular carcinoma. The challenge of multimodal diagnostic criteria |
Q73734234 | Recurrent hepatocellular carcinoma versus radiation-induced hepatic injury: differential diagnosis with MR imaging |
Q77369147 | Small hepatocellular carcinoma: assessment with T1-weighted spin-echo magnetic resonance imaging with and without fat suppression |
Q73597669 | Spin-echo echo-planar MR imaging of hepatocellular carcinoma arising from chronic liver damage: comparison with turbo spin-echo imaging |
Q33690177 | Susceptibility-weighted imaging for the noncontrast evaluation of hepatocellular carcinoma: a prospective study with histopathologic correlation |
Q37292309 | Synchronous multicentric small hepatocellular carcinomas: defining the capsule on high-frequency intraoperative ultrasonography with pathologic correlation |
Q71129555 | T2 relaxation times of hypervascular and non-hypervascular liver lesions: do hypervascular lesions mimic haemangiomas on heavily T2-weighted MR images? |
Q41234825 | The characterization of liver tumours by MRI. |
Q34588172 | Unique imaging issues in pediatric liver disease |
Q64259544 | Unusual MRI appearance of a well differentiated hepatocellular carcinoma, mimicking a cavernous hemangioma: A case report |
Search more.